HUP9801607A2 - Skin care composition containing retinoids and liposomes - Google Patents

Skin care composition containing retinoids and liposomes

Info

Publication number
HUP9801607A2
HUP9801607A2 HU9801607A HUP9801607A HUP9801607A2 HU P9801607 A2 HUP9801607 A2 HU P9801607A2 HU 9801607 A HU9801607 A HU 9801607A HU P9801607 A HUP9801607 A HU P9801607A HU P9801607 A2 HUP9801607 A2 HU P9801607A2
Authority
HU
Hungary
Prior art keywords
liposomes
composition containing
skin care
care composition
retinoids
Prior art date
Application number
HU9801607A
Other languages
Hungarian (hu)
Inventor
Jue-Chen Liu
Jonas C.T. Wang
Mohammed Yusuf
Original Assignee
Johnson & Johnson Consumer Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Products, Inc. filed Critical Johnson & Johnson Consumer Products, Inc.
Publication of HUP9801607A2 publication Critical patent/HUP9801607A2/en
Publication of HUP9801607A3 publication Critical patent/HUP9801607A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány szerinti készítmény nemfőszfőlipid lipőszómát ésretinőidként retinőlt, retinált, retinil-acetátőt, retinil-palmitátőtvagy ezek keverékét tartalmazza, valamint a következő valamelystabilizáló rendszert: a) őlajban őldható antiőxidáns, vagy b) egy kelátképző szer és legalább egy őlajban őldható antiőxidáns, akészítmény pH-ja legalább 5-10 közötti érték, és 13 hetes 50 C-őn valótártőlást követően a retinőid legalább 80%-a még megmarad. ŕThe preparation according to the invention contains non-maesopholipid liposome and retinyl, retinal, retinyl acetate, retinyl palmitate or a mixture of these as retinoids, as well as one of the following stabilizing systems: a) oil-soluble antioxidant, or b) a chelating agent and at least one oil-soluble antioxidant, the preparation pH- yes, at least a value between 5-10, and after 13 weeks of exposure at 50 C, at least 80% of your retinoids will still remain. ŕ

HU9801607A 1995-04-03 1996-04-03 Skin care composition containing retinoids and liposomes HUP9801607A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41597595A 1995-04-03 1995-04-03

Publications (2)

Publication Number Publication Date
HUP9801607A2 true HUP9801607A2 (en) 1999-01-28
HUP9801607A3 HUP9801607A3 (en) 1999-03-01

Family

ID=23648011

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801607A HUP9801607A3 (en) 1995-04-03 1996-04-03 Skin care composition containing retinoids and liposomes

Country Status (15)

Country Link
EP (1) EP0818988A2 (en)
JP (1) JPH11503165A (en)
KR (1) KR19980703668A (en)
CN (1) CN1185729A (en)
AP (1) AP789A (en)
AU (1) AU5532296A (en)
BR (1) BR9604954A (en)
CA (1) CA2217201A1 (en)
CZ (1) CZ311997A3 (en)
EA (1) EA199700289A1 (en)
HU (1) HUP9801607A3 (en)
NZ (1) NZ306694A (en)
OA (1) OA10520A (en)
PL (1) PL322624A1 (en)
WO (1) WO1996031194A2 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US6068847A (en) * 1996-10-03 2000-05-30 Johnson & Johnson Consumer Products, Inc. Cosmetic compositions
DE19713368A1 (en) * 1997-03-29 1998-10-01 Beiersdorf Ag Preparations with active ingredients sensitive to oxidation
FR2771636B1 (en) * 1997-12-01 2001-06-15 Capsulis IMPROVED METHOD FOR AVOIDING THE DEGRADATION OF AN ACTIVE INGREDIENT
FR2771635A1 (en) * 1997-12-01 1999-06-04 Capsulis Encapsulation of active materials in multilamellar vesicles containing an agent to prevent degradation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
DE19839402A1 (en) * 1998-08-29 2000-03-02 Beiersdorf Ag Stable oil-in-water retinoid emulsion useful for skin care contains selected emulsifier(s) based on e.g. glyceryl stearate and polyethylene glycol (PEG) 30 stearate
FR2787730B1 (en) 1998-12-29 2001-02-09 Oreal POLY (ALKYLENE ADIPATE) NANOCAPSULES, PROCESS FOR THEIR PREPARATION AND COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING THEM
JP3641152B2 (en) * 1999-02-17 2005-04-20 株式会社ヤクルト本社 Topical skin preparation
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
US20030003170A1 (en) 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
JP2001122735A (en) * 1999-10-28 2001-05-08 Kose Corp Skin lotion
US6468552B1 (en) 2000-06-02 2002-10-22 Neutrogena Corporation Stabilized compositions containing oxygen-labile active agents
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
KR100389670B1 (en) * 2000-12-21 2003-07-02 주식회사 티씨 싸이언스 A novel retinol derivative as an anti-aging agent and process for preparing thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
EP2127698B1 (en) 2001-02-28 2012-06-06 Johnson & Johnson Consumer Companies, Inc. Compositions containing legume products
US7547456B2 (en) 2001-03-16 2009-06-16 Johnson & Johnson Consumer Companies, Inc. Composition containing feverfew extract and use thereof
DE10117842A1 (en) * 2001-04-04 2002-10-17 Coty Bv Cosmetic vitamin A-containing preparation
US7081442B2 (en) 2001-05-21 2006-07-25 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
US6797697B2 (en) 2001-05-21 2004-09-28 Johnson & Johnson Consumer Companies, Inc. Composition containing a peptide and a pigment and the use thereof in darkening the skin
US7214655B2 (en) 2001-05-21 2007-05-08 Johnson & Johnson Consumer Companies, Inc. Peptides and the use thereof in darkening the skin
KR100439068B1 (en) * 2001-09-07 2004-07-05 주식회사 코리아나화장품 Stablized cosmetic material containing triple layered retonol
DE10212865B4 (en) * 2002-03-22 2005-05-04 Beiersdorf Ag Use of 9-retinal alkanolamine Schiff base in cosmetic dermatological formulations
AU2003213345A1 (en) * 2002-03-29 2003-10-13 Kose Corporation Cosmetic preparation
US7025951B2 (en) 2002-06-18 2006-04-11 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for darkening the skin
EP1572176A2 (en) * 2002-12-12 2005-09-14 Galderma Research & Development, S.N.C. Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid
DK2397133T3 (en) * 2004-06-18 2017-10-30 Univ Washington RETINAL DERIVATIVES AND METHODS OF USING ITS FOR TREATMENT OF VISION DISORDERS
US7381707B2 (en) 2005-06-30 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Treatment of dry eye
US20130149362A1 (en) * 2007-03-15 2013-06-13 Benjamin Johnson Treatment product and method
US20120141576A1 (en) * 2007-03-15 2012-06-07 Benjamin Johnson Treatment of Dermatologic Skin Disorders
WO2009131927A1 (en) 2008-04-21 2009-10-29 Mcneil-Ppc, Inc. Dual spray can topical delivery device
US8642655B2 (en) 2011-03-09 2014-02-04 Benjamin Johnson Systems and methods for preventing cancer and treating skin lesions
US20130004590A1 (en) 2011-06-28 2013-01-03 Lin Connie B Zinc oxide/acid containing compositions and methods for treating and/or preventing enzymatic irritation
CA2781212A1 (en) 2011-06-28 2012-12-28 Johnson & Johnson Consumer Companies, Inc. Divalent cation containing compositions and methods for treating and/or preventing enzymatic irritation
US20130004580A1 (en) 2011-06-28 2013-01-03 Lin Connie B Divalent cation/talc containing compositions and methods for treating and/or preventing enzymatic irritation
US9375388B2 (en) 2011-09-23 2016-06-28 Indian Institute Of Technology, Bombay Nanoparticle based cosmetic composition
KR102105210B1 (en) 2012-11-26 2020-04-27 코웨이 주식회사 Cosmetic composition of oil in water emulsion stabilized retinoids derivative
RU2016122918A (en) 2013-12-23 2018-01-30 Дэрмопартнерс, С.Л. METHOD FOR PRODUCING RETINALDEHYDE OR OTHER REDINAL ACID AND OTHER PRODUCED THIS PRODUCT BY LIPOS
KR102134931B1 (en) 2013-12-27 2020-07-16 코웨이 주식회사 Cosmetic composition comprising transparent and visible spherical particles
AU2016270434B2 (en) 2015-06-05 2019-07-11 MiRagen Therapeutics, Inc. miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)
CN108542848A (en) * 2018-05-24 2018-09-18 广州銮滢化妆品有限公司 A kind of crease-resistant topical composition and preparation method thereof containing nanometer retinene
US20210186845A1 (en) * 2019-12-18 2021-06-24 Barnet Products, LLC Vitamin a and vitamin c combinations with enhanced stability
KR102203420B1 (en) * 2020-08-10 2021-01-18 한국콜마주식회사 Liposome complex and cosmetic composition for improving skin condition comprising the same
CN114939079B (en) * 2022-05-19 2024-04-23 上海奥利实业有限公司 Preparation method and application of retinol and its derivative inclusion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653015B1 (en) * 1989-10-12 1993-10-29 Oreal COSMETIC OR PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION CONTAINING AT LEAST ONE RETINUID DERIVATIVE AND AT LEAST ONE PYRIMIDINE DERIVATIVE, ITS USE AS A MEDICINAL PRODUCT AND PROCESS FOR THEIR TREATMENT.

Also Published As

Publication number Publication date
HUP9801607A3 (en) 1999-03-01
NZ306694A (en) 2000-01-28
EP0818988A2 (en) 1998-01-21
EA199700289A1 (en) 1998-04-30
KR19980703668A (en) 1998-12-05
WO1996031194A3 (en) 1997-01-23
CN1185729A (en) 1998-06-24
PL322624A1 (en) 1998-02-02
JPH11503165A (en) 1999-03-23
WO1996031194A2 (en) 1996-10-10
AP9701101A0 (en) 1997-10-31
CZ311997A3 (en) 1998-01-14
BR9604954A (en) 1998-06-09
AP789A (en) 1999-12-03
OA10520A (en) 2002-04-22
AU5532296A (en) 1996-10-23
CA2217201A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
HUP9801607A2 (en) Skin care composition containing retinoids and liposomes
ATE365530T1 (en) STABILIZED SKIN CARE PRODUCT CONTAINING RETINOL FOR EXTERNAL USE
AU4323693A (en) Enniatines and enniatine derivates used to control endoparasites
NO954320L (en) Lyospheres comprising gonadotropin
CA2191789A1 (en) Biaromatic Compounds Containing an Adamantyl Group in Ortho Position; Pharmaceutical and Cosmetic Compositions Containing Them and Use Thereof
ES2061252T3 (en) ANTITUSIVE AGENT AND REGULATOR OF THE MUCOSA, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
HUP9901144A2 (en) Pharmaceutical compositions containing new associations of clopidogrel and an antithrombotic agent
HUP0102521A2 (en) Antitumor agents comprising a stilbene derivative and a platinum coordination compound
ES2136723T3 (en) USE OF N-ARYL-METHYLENE-ETHYL-DIAMINE-TRIACETATES, N-ARYL-METHYLENE-IMINO-DIACETATES OR N, N'-DIARYL-METHYLENE-DIAMINE-ACETATES AGAINST OXIDIZING STRESS.
HUP9801240A2 (en) Oral compositions
MX9605741A (en) (r)-(-)-2-{n-[4-(1,1-dioxide-3-oxo-2,3-dihydro-benzisotiazole-2-yl)-buty l]-aminomethyl}-cromane crystalline chlorhydrate.
DK0676948T3 (en) Oral anti-plaque, anti-gingivitis, anti-caries composition
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
BR0207654A (en) Composition comprising a base cream or lotion
MY130044A (en) Retinoid composition
HUP0003571A2 (en) 6,9-bridged erythromycin derivatives
HUP9801414A2 (en) Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate
HUP9900365A3 (en) N-aryl-1,2,4-triazolin-5-on derivatives, preparation and use thereof, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients
FI972434A0 (en) Pharmaceutical composition containing lamotrigine
BR9812222A (en) Pharmaceutical preparation separate from prothrombin complex, diagnostic preparation, and use of a preparation
HUP0004064A2 (en) Dentrifice composition
DE69613395D1 (en) SULFUR-CONTAINING DI-TER-BUTYLPHENOL COMPOUNDS USED AS AN ANTI-FLAMMING AGENT
WO2001043705A3 (en) Compositions containing a retinoid and a stilbene for skin care
SE9403389D0 (en) Pharmaceutical composition containing derivatives of sex hormones
CA2169696A1 (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished